Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences

View all Images (6)

Multiple carboxylase deficiency
Other Resources UpToDate PubMed

Multiple carboxylase deficiency

Contributors: Jeffrey D. Bernhard MD, Craig N. Burkhart MD, Dean Morrell MD, Lowell A. Goldsmith MD, MPH
Other Resources UpToDate PubMed

Synopsis

Biotin deficiency due to a recessively inherited genetic defect of biotinidase, genetic defects of several carboxylases, or holocarboxylase synthetase mutations causes profound metabolic defects that can lead to permanent nervous system damage and even death. Biotinidase releases biotin from foods or from endogenous peptides. Free biotin is essential for activating 4 coenzyme A (CoA)-containing or -dependent carboxylases that have essential roles in protein catabolism, fatty acid synthesis, and gluconeogenesis. Holocarboxylase synthetase incorporates biotin into the 4 carboxylases. Biotinidase and holocarboxylase synthetase deficiency can be treated with pharmacologic doses of oral biotin.

These deficiencies are screened for in all newborns in the United States and several other countries. Biotinidase deficiency has an overall incidence of about 1:60 000 newborns. In California, biotinidase deficiency has a higher incidence in Hispanics of Mexican descent. The disorder has been found worldwide in all populations and ethnic groups.

Biotinidase deficiency can be profound or partial; profound and partial deficiencies of biotinidase are the most common forms of the multiple carboxylase-related deficiencies.

Profound biotinidase deficiency – Mean age of onset is 3.5 months; onset often occurs by 1 week of age. If untreated, patients may develop the following:
  • Seizures (often myoclonic) and hypotonia
  • Sensorineural deafness, ataxia and optic atrophy, and developmental delay
  • Hyperventilation, respiratory stridor, and apnea
  • Alopecia (rarely, trichorrhexis changes have been reported in remaining hairs)
  • Perioral and periorificial eruptions than can be generalized, cutaneous Candida infections, and conjunctivitis
  • Metabolic changes including keto-lactic acidosis, organic aciduria and increased ammonia levels, and hypoglycemia
Partial biotinidase deficiency – Similar symptoms but to a lesser degree, and later onset or onset only with metabolic stress such as infection.

Holocarboxylase synthetase deficiency and defects in the other carboxylases are often detected by neonatal screening programs analyzing organic acids.

Codes

ICD10CM:
D81.819 – Biotin-dependent carboxylase deficiency, unspecified

SNOMEDCT:
8808004 – Biotinidase deficiency

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Updated:01/19/2022
Copyright © 2024 VisualDx®. All rights reserved.
Multiple carboxylase deficiency
Print   View all Images (6)
(with subscription)
A medical illustration showing key findings of Multiple carboxylase deficiency : Seizures, Ataxia, Hearing loss, Hypoglycemia, Metabolic acidosis, Optic disc atrophy, Scaly plaque, Alopecia, Stridor
Clinical image of Multiple carboxylase deficiency - imageId=5460992. Click to open in gallery.
Copyright © 2024 VisualDx®. All rights reserved.